Shoulder1: Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Unknown status
CT.gov ID
NCT04110665
Collaborator
(none)
200
1
4
39
5.1

Study Details

Study Description

Brief Summary

This study evaluates the addition of tramadol, or nefopam or opioid to paracetamol and ketoprofene in the treatment of pain in adults after shoulder ambulatory surgery. In a first step, 30 patients will receive tramadol as rescue analgesia in combination with paracetamol and ketoprofene, while the other will receive nefopam or opioid in a sequential analysis that will be performed every 20 patients using the QoR 40 survey.

Condition or Disease Intervention/Treatment Phase
  • Drug: Tramadol
  • Drug: Nefopam 20 MG/ML
  • Drug: Morphine Sulfate
  • Drug: Oxycodone 20mg
Phase 4

Detailed Description

Multimodal analgesia using acetaminophen with non steroidal anti inflammatory is commonly used for pain relief after ambulatory surgery. Tramadol achieves pain relief when rescue analgesia is needed after this surgery, but induces side effects (nausea, vomiting, discomfort, sleep disorder...). Other drugs could be used to reduce the side effects of tramadol and improve postoperative experience : nefopam or opioid (immediate or delayed release medication). Using a survey that describes pain, comfort, emotion or physical status (QoR 40), the investigators analyse the impact of various multimodal strategies using tramadol or nefopam or opioid that is necessary to improve postoperative experience.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Evaluation of the treatment based on QoR40 survey every 20 patientsEvaluation of the treatment based on QoR40 survey every 20 patients
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Multimodal Oral Strategies Using Sequential Analysis (Tramadol, Opioid) After Shoulder Ambulatory Surgery
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Sep 30, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Paracetamol+ ketoprofene and Tramadol

Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours were systematically administered. Tramadol 100 mg per os every 6 hours was added when pain was > 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).

Drug: Tramadol
Tramadol 100 mg tablet
Other Names:
  • Paracetamol
  • Ketoprofene
  • Active Comparator: Paracetamol+ ketoprofene+ Nefopam and Tramadol

    Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours and Nefopam 120 mg intravenously were systematically administered. Tramadol 100 mg per os every 6 hours was added when pain was > 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).

    Drug: Tramadol
    Tramadol 100 mg tablet
    Other Names:
  • Paracetamol
  • Ketoprofene
  • Drug: Nefopam 20 MG/ML
    120 mg for 24 hours
    Other Names:
  • Paracetamol
  • Ketoprofene
  • Tramadol
  • Active Comparator: Paracetamol+ ketoprofene and morphine

    Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours were systematically administered. Opioid immediate release (morphine 10 mg) per os every 6 hours was added when pain was > 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).

    Drug: Morphine Sulfate
    Tablet 10mg
    Other Names:
  • Paracetamol
  • Ketoprofene
  • Active Comparator: Paracetamol+ ketoprofene+Opioid delayed release and morphine

    Paracetamol per os 1g every 6 hours and ketoprofene 100 mg per os every 12 hours and 20 mg of opioid delayed release (Oxycodone) were systematically administered. Opioid immediate release (morphine 10 mg) per os every 6 hours was added when pain was > 3/10 on a numeric ranking scale (0 no pain, 10 worst pain).

    Drug: Morphine Sulfate
    Tablet 10mg
    Other Names:
  • Paracetamol
  • Ketoprofene
  • Drug: Oxycodone 20mg
    release
    Other Names:
  • Paracetamol
  • Ketoprofene
  • Morphine Sulfate
  • Outcome Measures

    Primary Outcome Measures

    1. Quality of Recovery (QoR) 40 survey [Day 2]

      score based on 200 points (minimum 40, maximum 200), 40 questions (5 points for each question)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • shoulder surgery

    • under general anesthesia with an nterscalenic block

    • written informed consent

    • age > 18 years

    Exclusion Criteria:
    • age < 18years

    • emergency surgery

    • refusal

    • drug or opioid abuses

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU de Nimes Nîmes France 30029

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nīmes

    Investigators

    • Study Director: benjamin Garnaud, MD, CHU Nimes, Nimes University, France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Philippe Cuvillon, Clinical Professor, Head of Anesthesia department, Centre Hospitalier Universitaire de Nīmes
    ClinicalTrials.gov Identifier:
    NCT04110665
    Other Study ID Numbers:
    • AOI 2017-1316-47
    First Posted:
    Oct 1, 2019
    Last Update Posted:
    Oct 1, 2019
    Last Verified:
    Sep 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Philippe Cuvillon, Clinical Professor, Head of Anesthesia department, Centre Hospitalier Universitaire de Nīmes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 1, 2019